IP Library Granted Patent US 8,834,350
Granted Patent B2
US 8,834,350 · App. 12/308,436 · Granted Sep 16, 2014

Surgical implants, tools, and methods for treating pelvic conditions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,834,350
App. No.
12/308,436
Granted
Sep 16, 2014
Kind
B2
Abstract

Described are pelvic implants (e.g., urinary incontinence sling, hammock, etc.) that provide treatment for pelvic floor disorders such as incontinence, stress urinary incontinence, prolapse (e.g., cystocele, enterocele, rectocele, vault prolapse), fecal incontinence, and the like, wherein the implant involves the ability to adjust dimensions of an implant before, during, or after implantation. In a preferred embodiment the implant ( 680 ) comprises a support portion piece ( 682 ) and an extension portion piece ( 688, 690 ) adjustably connected to the support portion piece through a frictional adjusting element ( 696 ) comprising an aperture through which a segment of extension portion extends.

Claims (21)

1. A multi-piece pelvic implant comprising a tissue support portion, a first extension portion, and a second extension portion, the implant comprising pieces that include:

a support portion piece comprising the tissue support portion,

the first extension portion comprising a first extension portion piece, and

the second extension portion comprising a second extension portion piece,

wherein the first extension portion piece is adjustably connected to the support portion piece, and the implant includes a first frictional adjusting element that allows adjustment of a length of the first extension portion, the first frictional adjusting element comprising a first aperture through which a segment of the first extension portion extends and a surface that frictionally engages the segment of the first extension portion, wherein the first frictional adjusting element preferentially allows movement of the segment of the first extension portion through the aperture in one direction and inhibits movement of the segment of the first extension portion in an opposing direction,

wherein the second extension portion piece is adjustably connected to the support portion piece, and the implant includes a second frictional adjusting element that allows adjustment of a length of the second extension portion, the second frictional adjusting element comprising a second aperture through which a segment of the second extension portion extends and a surface that frictionally engages the segment of the second extension portion, wherein the second frictional adjusting element preferentially allows movement of the segment of the second extension portion through the second aperture in one direction and inhibits movement of the segment of the second extension portion in an opposing direction,

wherein the first frictional adjusting element comprises a grommet and the second frictional adjusting element comprises a grommet.

2. The implant of claim 1 wherein the first frictional adjusting element is secured to the implant at a location selected from the tissue support portion of the support portion piece, a support portion piece arm, and the first extension portion piece, and wherein the second frictional adjusting element is secured to the implant at a location selected from the tissue support portion of the support portion piece, a support portion piece arm, and the second extension portion piece.

3. The implant of claim 2 wherein the first and second frictional adjusting elements are secured to a proximal end of the first and second extension portion pieces.

4. The implant of claim 1 wherein the support portion piece comprises

the tissue support portion,

at least two support portion piece arms extending from the tissue support portion, and

the first and the second frictional adjusting elements secured to the support portion piece arms.

5. The implant of claim 1 wherein

the first frictional adjusting element is secured to a proximal end of the first extension portion piece,

a tissue fastener is attached at a distal end of the first extension portion piece, and

the support portion piece comprises an elongate support portion piece arm extending through the first frictional adjusting element aperture.

6. The implant according to claim 1 comprising the tissue support portion and four extension portions including two superior extension portions of fixed length and two inferior extension portions of adjustable length.

7. The implant of claim 1 , wherein the grommet of the first frictional adjusting element is located at the first extension portion piece, and the grommet of the second frictional adjusting element is located at the second extension portion piece.

8. The implant of claim 1 , wherein the grommet of the first frictional adjusting element is secured to the support portion piece, and the grommet of the second frictional adjusting element is secured to the support portion piece.

9. In combination, the pelvic implant according to claim 1 and an adjusting tool, the adjusting tool comprising an elongate shaft and a distal end, the distal end being capable of engaging the grommet of the first frictional adjusting element to move the grommet of the first adjusting element along a length of the segment of the first extension portion.

Assignments (12)
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: BOSTON SCIENTIFIC CORPORATION
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 043780/0316 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: ASTORA WOMEN'S HEALTH, LLC; ENDO HEALTH SOLUTIONS INC.; ASTORA WOMEN'S HEALTH HOLDINGS, LLC
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043778/0302 →
SECURITY INTEREST Recorded Jun 8, 2017
From: ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0278 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY DATA NAME PREVIOUSLY RECORDED AT REEL: 037300 FRAME: 0728. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Apr 21, 2017
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 042308/0630 →
CHANGE OF NAME Recorded Jan 18, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037551/0749 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037551/0626 →
CHANGE OF NAME Recorded Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0728 →
RELEASE OF SECURITY INTEREST Recorded Aug 6, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: AMERICAN MEDICAL SYSTEMS, LLC; AMS RESEARCH, LLC; LASERSCOPE
Reel/Frame 036285/0146 →
GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.; LASERSCOPE
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
RELEASE OF PATENT SECURITY INTEREST Recorded Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: AMS RESEARCH CORPORATION
Reel/Frame 032380/0053 →
SECURITY AGREEMENT Recorded Jul 22, 2011
From: AMS RESEARCH CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 026632/0535 →